Practical Considerations in Using T-VEC for Advanced Melanoma

Practical Considerations in Using T-VEC for Advanced Melanoma

Publication date: Aug 10, 2021

Dr. Aman Shah of PracticeUpdate interviews Igor Puzanov MD, MSCI, FACP on Practical Considerations in Using T-VEC for Advanced Melanoma Video originally published on PracticeUpdate. com on 12/30/2019 — https://www. practiceupdate. com/content/practical-considerations-in-using-t-vec-for-advanced-melanoma/90842/45/1/3 — Follow PracticeUpdate: Twitter: https://twitter. com/practiceupdate Facebook: https://www. facebook. com/practiceupdate Instagram: https://www. instagram. com/practiceupdate_elsevier LinkedIn: https://www. linkedin. com/showcase/practiceupdate Register for PracticeUpdate for free at https://www. practiceupdate. com/welcome

Concepts Keywords
Complete Melanoma
Facebook Virotherapy
Nurse Antineoplastic drugs
Practiceupdate_elsevier Cancer
Tibet Clinical medicine
Medicine
Health sciences
Talimogene laherparepvec
Checkpoint inhibitor

Semantics

Type Source Name
drug DRUGBANK Talimogene laherparepvec
disease MESH Melanoma
pathway KEGG Melanoma
drug DRUGBANK Coenzyme M
disease MESH tumors
disease MESH community

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *